Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur significant order book increase in a growing market is a great sign of confidence.
Read our latest reportUrenco Limited is pleased to announce the appointment of Evelyn Dickey as a new UK Non-Executive Director.
Evelyn is joining us from the Nuclear Decommissioning Authority (NDA), where she is a Non-Executive Member of the Board and Chair of the Remuneration Committee until January next year.
She succeeds Justin Manson after he was appointed Chairman of the Board in July, who commented: “I am pleased to welcome Evelyn to our Board with the substantial nuclear energy and human resources experience that she brings. This will be invaluable during a time of great momentum and opportunity within our industry.”
Urenco shared a stage with big-tech companies DOW, Google and Amazon, as the large energy users signed a pledge to support the tripling of nuclear capacity globally by 2050.
Read more Urenco welcomes nuclear pledge from major companiesUrenco shared a stage with big-tech companies DOW, Google and Amazon, as the large energy users signed a pledge to support the tripling of nuclear capacity globally by 2050.
Read more Urenco welcomes nuclear pledge from major companiesSignificant order book increase in a growing market.
Read more Full year 2024 audited financial resultsSignificant order book increase in a growing market.
Read more Full year 2024 audited financial resultsAbout Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries